This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coty's Turnaround Plans Robust, Consumer Beauty Unit Hurts
by Zacks Equity Research
Coty (COTY) is making solid efforts to bring a turnaround to its business. The company's Consumer Beauty segment has been soft for a while.
Here's How Kimberly-Clark (KMB) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Increased demand owing to consumer stockpiling trends amid the coronavirus outbreak is likely to get reflected in Kimberly-Clark's (KMB) second-quarter 2020 performance.
Factors to Decide the Fate of Coca-Cola (KO) in Q2 Earnings
by Zacks Equity Research
Coca-Cola's (KO) Q2 results are likely to reflect the impacts of declines in away-from-home channels and adverse currency. Growth in e-commerce is likely to have party cushioned its performance.
The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg
Boston Beer (SAM) to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are likely to reflect continued gains from strength in depletions and shipments. Soft on-premise demand and higher costs are expected to have marred its performance.
5 Consumer Staple Stocks to Buy With Earnings Beat Potential
by Vrishali Bagree
We have picked five consumer staple stocks, which are likely to report earnings beat this season owing to the burgeoning demand amid the pandemic-led increased at-home consumption.
Top Ranked Growth Stocks to Buy for July 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 15th.
Estee Lauder's (EL) Robust E-commerce Business Bodes Well
by Zacks Equity Research
Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.
Helen of Troy (HELE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Helen of Troy (HELE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Philip Morris' (PM) IQOS Gets FDA Nod to be Marketed as MRTP
by Zacks Equity Research
Philip Morris (PM) is likely to benefit from the FDA's latest move. Notably, the FDA authorizes IQOS's marketing as a modified risk tobacco product.
Moving Average Crossover Alert: Nu Skin Enterprises
by Zacks Equity Research
Nu Skin Enterprises, Inc. (NUS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Will Nu Skin Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of Nu Skin Enterprises
Nu Skin (NUS) Revises Q2 Sales View Upward, Stock Rises
by Zacks Equity Research
Nu Skin (NUS) witnesses robust consumer growth during second-quarter 2020. The company raises sales guidance for the quarter.
Inter Parfums' IPSA Buys Stake in Owner of Origines-parfums
by Zacks Equity Research
Inter Parfums' (IPAR) majorly owned subsidiary ??? Interparfums SA or IPSA ??? pens a deal to buy 25% stake in Divabox. Divabox is the owner of Origines-parfums.
Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business
by Zacks Equity Research
Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.
3 Factors That Make Helen of Troy (HELE) an Attractive Pick
by Zacks Equity Research
Strength in Helen of Troy's (HELE) Leadership Brands is driving growth. Moreover, the company's focus on enhancing online business is yielding.
Tap Market Potential With These 4 Consumer Staples Stocks
by Rajani Lohia
Consumer staples sector shows resilience amid the pandemic due to strong demand for food and other essentials. Efforts to keep pace with consumer trends should bolster the sector's growth.
Kimberly-Clark (KMB) Looks Scrumptious on Cost-Saving Efforts
by Zacks Equity Research
Kimberly-Clark (KMB) is witnessing higher consumer demand owing to coronavirus induced stockpiling. Also, robust cost-saving efforts bode well.
Estee Lauder Benefits From Online Sales Amid Store Closures
by Zacks Equity Research
Estee Lauder (EL) is gaining from solid online sales amid coronavirus-led store closures. Also, the company's efficient cost-saving efforts are yielding.
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
Why Nu Skin (NUS) Could Be a Top Value Stock Pick
by Zacks Equity Research
Nu Skin (NUS) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
5 Consumer Staple Dividend Stocks to Enrich Your Portfolio
by Vrishali Bagree
At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.
Kraft Heinz Pricing & Efficiency Building Efforts Bode Well
by Zacks Equity Research
Kraft Heinz (KHC) is benefitting from its robust pricing and product-development efforts. Also, the company's enterprise transformation strategies bode well.
Mondelez's Pricing Strategies Bodes Well, Input Costs a Woe
by Zacks Equity Research
Mondelez (MDLZ) is benefiting from efficient pricing and impressive savings plan. However, higher costs and unfavorable currency rates are troubling.
Here's Why Helen of Troy (HELE) is Up More Than 35% in a Year
by Zacks Equity Research
Helen of Troy's (HELE) focus on Leadership Brands, sturdy digital efforts and Transformation Plan bode well. It is seeing strong demand in the Health & Home unit thanks to the COVID-19 pandemic.